Skip to content

MAS A.G.: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MAS A.G.

BE 0818.817.283
NACE 21.209, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€17.8m
2024 · €34.0m-€16.1m
Equity
€29.6m
2024 · €16.8m+€12.8m
Cash
€3.9m
2024 · €18.0m-€14.1m
Balance sheet total
€34.7m
2024 · €47.2m-€12.5m

Largest movements

2024 to 2025
Assets
  • Cash -€14.1m

    down €14.1m (-78.2%), from €18.0m to €3.9m

    mainly Other debts (-€25.0m) and Contributions, distributions and other (-€5.0m)

  • Current investments +€3.1m

    up €3.1m (+62.1%), from €5.0m to €8.1m

  • Receivables within one year -€1.5m

    down €1.5m (-66.9%), from €2.2m to €743,951

    of which Other amounts receivable: -€1.5m

Equity and liabilities
  • Other debts -€25.0m

    down €25.0m (-83.3%), from €30.0m to €5.0m

  • Profit (loss) carried forward +€12.8m

    up €12.8m (+140%), from €9.2m to €22.0m

Income statement
  • Financial income -€16.6m

    down €16.6m (-52.0%), from €31.9m to €15.3m

  • Taxes -€584,264

    down €584,264 (-37.1%), from €1.6m to €990,499

  • Gross operating margin -€149,213

    down €149,213 (-4.1%), from €3.6m to €3.5m

  • Financial charges -€37,129

    down €37,129 (-99.4%), from €37,343 to €214

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €34.0m
Gross operating margin -€149,213
Other operating charges +€86
Financial income -€16.6m
Financial charges +€37,129
Taxes +€584,264
Result 2025 €17.8m
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€6.0m
Investment -€3.1m
Financing -€5.0m
Cash 2024 €18.0m
Net result for the year +€17.8m
Receivables within one year +€1.5m
Smaller working-capital items +€1,088
Tax, wage and social debts -€314,136
Other debts -€25.0m
Current investments -€3.1m
Contributions, distributions and other -€5.0m
Cash 2025 €3.9m
brings cash intakes cash out
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €47,184,596 €34,677,014 -€12.5m -26.5%
Fixed assets 21/28 €21,900,000 €21,900,000 = 0.0%
Financial fixed assets 28 €21,900,000 €21,900,000 = 0.0%
Current assets 29/58 €25,284,596 €12,777,014 -€12.5m -49.5%
Amounts receivable within one year 40/41 €2,245,317 €743,951 -€1.5m -66.9%
Trade receivables 40 €381,680 €427,045 +€45,365 +11.9%
Other amounts receivable 41 €1,863,636 €316,906 -€1.5m -83.0%
Current investments 50/53 €5,000,000 €8,105,612 +€3.1m +62.1%
Cash at bank and in hand 54/58 €18,039,279 €3,927,426 -€14.1m -78.2%
Deferred charges and accrued income 490/1 - €25 +€25
Total equity and liabilities 10/49 €47,184,596 €34,677,014 -€12.5m -26.5%
Equity 10/15 €16,775,024 €29,580,465 +€12.8m +76.3%
Contributions 10/11 €63,000 €63,000 = 0.0%
Capital 10 €63,000 €63,000 = 0.0%
Issued capital 100 €63,000 €63,000 = 0.0%
Reserves 13 €7,553,020 €7,553,020 = 0.0%
Non-distributable reserves 130/1 €6,300 €6,300 = 0.0%
Legal reserve 130 €6,300 €6,300 = 0.0%
Tax-exempt reserves 132 €3,229,070 €1,376,670 -€1.9m -57.4%
Distributable reserves 133 €4,317,650 €6,170,050 +€1.9m +42.9%
Profit (loss) carried forward 14 €9,159,004 €21,964,445 +€12.8m +140%
Amounts payable 17/49 €30,409,572 €5,096,549 -€25.3m -83.2%
Amounts payable within one year 42/48 €30,409,572 €5,096,549 -€25.3m -83.2%
Trade debts 44 €21,537 €22,650 +€1,113 +5.2%
Suppliers 440/4 €21,537 €22,650 +€1,113 +5.2%
Taxes, remuneration and social security 45 €388,035 €73,899 -€314,136 -81.0%
Taxes 450/3 €388,035 €73,899 -€314,136 -81.0%
Other amounts payable 47/48 €30,000,000 €5,000,000 -€25.0m -83.3%
Other operating charges 640/8 €1,173 €1,086 -€86 -7.4%
Gross operating margin 9900 €3,620,257 €3,471,044 -€149,213 -4.1%
Operating profit (loss) 9901 €3,619,084 €3,469,958 -€149,127 -4.1%
Financial income 75/76B €31,944,434 €15,326,197 -€16.6m -52.0%
Recurring financial income 75 €31,944,434 €15,326,197 -€16.6m -52.0%
Financial charges 65/66B €37,343 €214 -€37,129 -99.4%
Recurring financial charges 65 €37,343 €214 -€37,129 -99.4%
Profit (loss) for the period before taxes 9903 €35,526,176 €18,795,940 -€16.7m -47.1%
Income taxes 67/77 €1,574,764 €990,499 -€584,264 -37.1%
Profit (loss) for the period 9904 €33,951,412 €17,805,441 -€16.1m -47.6%
Profit (loss) for the period to be appropriated 9905 €33,951,412 €17,805,441 -€16.1m -47.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.